Ann Arbor-based Genomenon has won a Small Business Innovation Research (SBIR) grant from the NIH’s National Human Genome Research Institute (NHGRI). Funding from the grant, valued at $152,946, will go toward creating a platform for producing and sharing “micropublications” across the genomics research community, as well as continuing Genomenon’s efforts to automate variant interpretation based on data from published studies. The news was covered in Clinical OMICS .
“This grant allows us to build on the work from our last successful NIH funding to increase the automation of variant interpretation and allow users to rapidly share their findings across the scientific community.” said Genomenon’s Co-founder and CSO, Dr. Mark Kiel in statement on the company's website. “This automated micropublication platform will help accelerate the sharing of knowledge as more and more genomic research is being published every year.
Genomenon's CEO Mike Klein was the Showcase presenter at New Enterprise Forum in June 2017. Earlier this year, Genomenon announced that it had completed a $2.5M equity financing round. Investors in that round included IrishAngels, H. W. Kaufman Group, and all of Genomenon’s earlier investors.